Unveiling the Role of Exosomes in the Pathophysiology of Sepsis: Insights into Organ Dysfunction and Potential Biomarkers

Int J Mol Sci. 2024 Apr 30;25(9):4898. doi: 10.3390/ijms25094898.

Abstract

Extracellular vesicles (EVs) are tools for intercellular communication, mediating molecular transport processes. Emerging studies have revealed that EVs are significantly involved in immune processes, including sepsis. Sepsis, a dysregulated immune response to infection, triggers systemic inflammation and multi-organ dysfunction, posing a life-threatening condition. Although extensive research has been conducted on animals, the complex inflammatory mechanisms that cause sepsis-induced organ failure in humans are still not fully understood. Recent studies have focused on secreted exosomes, which are small extracellular vesicles from various body cells, and have shed light on their involvement in the pathophysiology of sepsis. During sepsis, exosomes undergo changes in content, concentration, and function, which significantly affect the metabolism of endothelia, cardiovascular functions, and coagulation. Investigating the role of exosome content in the pathogenesis of sepsis shows promise for understanding the molecular basis of human sepsis. This review explores the contributions of activated immune cells and diverse body cells' secreted exosomes to vital organ dysfunction in sepsis, providing insights into potential molecular biomarkers for predicting organ failure in septic shock.

Keywords: circulating exosomes; molecular biomarkers; pathophysiology; sepsis; septic shock; vital organ dysfunction.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers*
  • Exosomes* / metabolism
  • Humans
  • Multiple Organ Failure* / etiology
  • Multiple Organ Failure* / immunology
  • Multiple Organ Failure* / metabolism
  • Sepsis* / metabolism

Substances

  • Biomarkers

Grants and funding

M.P. was supported by the Medical School, University of Pécs, KA Research Grant KA-2022-21 (grant number 304566). T.A.R. was supported by the Gyula Kispál scholarship of the Medical School, University of Pécs, and received funding from the National Research, Development and Innovation Fund, Hungary (grant number: K131588). The project TKP2021-EGA-17 in Hungary was funded by the National Research, Development and Innovation Office (NKFIH).